ASSET | DATE | % RETURN |
---|---|---|
Intuitive Machines (LUNR) | 2/14/2024 - 2/20/2024 | 129.92% |
Ocugen (OCGN) | 2/14/2024 - 2/20/2024 | 70.49% |
Nano X Imaging (NNOX) | 2/14/2024 - 2/20/2024 | 68.13% |
Phathom Pharmaceuticals (PHAT) | 2/14/2024 - 2/20/2024 | 56.46% |
Trevi Therapeutics (TRVI) | 2/14/2024 - 2/20/2024 | 44.21% |
Taysha Gene Therapies (TSHA) | 2/14/2024 - 2/20/2024 | 43.33% |
Gyre Therapeutics (GYRE) | 2/14/2024 - 2/20/2024 | 35.91% |
Rezolute (RZLT) | 2/14/2024 - 2/20/2024 | 35.51% |
Ocular Therapeutix (OCUL) | 2/14/2024 - 2/20/2024 | 32.39% |
Arcutis Biotherapeutics (ARQT) | 2/14/2024 - 2/20/2024 | 31.85% |
Nyxoah (NYXH) | 2/14/2024 - 2/20/2024 | 31.7% |
Gossamer Bio (GOSS) | 2/14/2024 - 2/20/2024 | 31.39% |
Doubledown Interactive (DDI) | 2/14/2024 - 2/20/2024 | 31.1% |
GeneDx (WGS) | 2/14/2024 - 2/20/2024 | 31% |
Now (DNOW) | 2/14/2024 - 2/20/2024 | 30.38% |
Jumia Technologies (JMIA) | 2/14/2024 - 2/20/2024 | 28.62% |
Anterix (ATEX) | 2/14/2024 - 2/20/2024 | 28.22% |
Gold Royalty (GROY) | 2/14/2024 - 2/20/2024 | 27.66% |
Kornit Digital (KRNT) | 2/14/2024 - 2/20/2024 | 27.42% |
Sana Biotechnology (SANA) | 2/14/2024 - 2/20/2024 | 27.39% |
Iovance Biotherapeutics (IOVA) | 2/14/2024 - 2/20/2024 | 26.9% |
Byrna Technologies (BYRN) | 2/14/2024 - 2/20/2024 | 26.71% |
Solid Biosciences LLC (SLDB) | 2/14/2024 - 2/20/2024 | 26.25% |
Codere Online US (CDRO) | 2/14/2024 - 2/20/2024 | 25.33% |
ProKidney (PROK) | 2/14/2024 - 2/20/2024 | 25% |